EP2575881
ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.5.2011:
14.9.2016:
11728594.0
:
26.5.2031
:
ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
27.5.2011
14.9.2016
:
INSERM - Institut National de la Santé et de la Recherche Médicale:
101, rue de Tolbiac, 75013, Paris, FR
:
Elsalys Biotech:
321 avenue Jean Jaures, 69007, Lyon, FR
:
LE BOUTEILLER, Philippe:
F-31024 Toulouse Cédex 3, FR
:
BENSUSSAN, Armand:
Paris, FR
:
349271 P:
28.5.2010:
US
:
EP2011058777:
27.5.2011
:
A61K 39/00, A61K 9/00, A61K 39/395, A61P 27/02, C07K 16/28, C07K 16/22